Random

Mesoblast Finalizes $90 Million Financing for COVID-19 Treatment

Andrew M. - May 27, 2020

FDA Approves Landmark COVID/Heart/CBD Clinical Trial

Paul Archie - September 30, 2020

Biogen Announces Q2 Results, Seeks FDA Review of Alzheimer’s Drug

Andrew M. - July 24, 2020

Biotech Insights

Home Biotech Insights

Biotech Insights

ImmunoGen Reports Narrower Q1 Loss, Recent Progress

BiotechStocktrader - May 8, 2020

Biotech Insights

Genocea Biosciences Stock Continues to Climb Following Q2 Update

Andrew M. - July 24, 2020

Biotech Insights

Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s...

Paul Archie - December 15, 2020

Biotech Insights

Recro Pharma Shares Fall as Pandemic Weighs on Results

Andrew M. - August 11, 2020

12 3...13 Page 1 of 13

- Advertisement -

LATEST NEWS

Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...

Paul Archie - March 2, 2021

Big Pharma Dives Into CBD: Who Could Be Next?

Paul Archie - February 22, 2021

Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™

Paul Archie - December 22, 2020

Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...

Paul Archie - December 8, 2020

LATEST INTERVIEWS